EE5 Cost-Utility Analysis of Aripiprazole, Olanzapine Branded Generic, and Olanzapine Generic on Stable Phase of Schizophrenia Patient at Mental Health Hospital in Jakarta
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.260
https://www.valueinhealthjournal.com/article/S1098-3015(22)02464-0/fulltext
Title :
EE5 Cost-Utility Analysis of Aripiprazole, Olanzapine Branded Generic, and Olanzapine Generic on Stable Phase of Schizophrenia Patient at Mental Health Hospital in Jakarta
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02464-0&doi=10.1016/j.jval.2022.09.260
First page :
Section Title :
Open access? :
No
Section Order :
12063